+12.7%
GSK vs CAPR
+64.2%
-51.5%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CAPR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | +9.4% | -7.0% | +2.4% |
| 7D | +4.9% | +36.0% | -31.1% | +4.7% |
| 30D | +10.8% | +25.8% | -15.0% | +10.7% |
| 3M | -1.8% | +140.8% | -142.6% | -2.3% |
| 6M | +4.1% | -67.6% | +71.7% | +4.3% |
| YTD | +7.9% | -65.9% | +73.7% | +8.0% |
| All | +12.7% | +64.2% | -51.5% | +11.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CAPR.
Daily Out/Under-Performance
Portfolio return minus CAPR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CAPR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CAPR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling